Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchNo recent work listed

Ashleigh Parkin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5058096024. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2018: 3 papers · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper

Papers 8

  1. Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status. Co-author DOI 10.1126/sciadv.abh0363↗
  2. MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41388-019-1091-0↗
  3. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/thno.43589↗
  4. Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy. Co-author DOI 10.1111/febs.15011↗
  5. PAK inhibition by PF-3758309 enhanced the sensitivity of multiple chemotherapeutic reagents in patient-derived pancreatic cancer cell lines. Co-author PMID 31312349↗
  6. Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2017-315144↗
  7. The PAK Inhibitor PF-3758309 Promotes the Inhibitory Effects of Multiple Chemotherapeutic Reagents on Patient-Derived Pancreatic Cancer Cell Lines Co-author DOI 10.20944/preprints201809.0322.v1↗
  8. The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/diseases6040103↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marina Pajic · 8 shared papers, 2018–2021 · strength 0.70
  2. Paul Timpson · 5 shared papers, 2018–2021 · strength 0.44
  3. Jennifer Man · 4 shared papers, 2018–2019 · strength 0.40
  4. Angela S. Y. Chou · 4 shared papers, 2018–2021 · strength 0.30
  5. Jaswinder Singh Samra · 3 shared papers, 2018–2021 · strength 0.22
  6. Anthony James Gill · 3 shared papers, 2018–2021 · strength 0.22
  7. Amber L. Johns · 3 shared papers, 2018–2021 · strength 0.22
  8. Kendelle Joan Murphy · 3 shared papers, 2018–2021 · strength 0.22
  9. Hong Zhen He · 2 shared papers, 2018–2019 · strength 0.18
  10. Mehrdad Nikfarjam · 2 shared papers, 2018–2019 · strength 0.18
  11. Australian Pancreatic Cancer Genome Initiative (APGI) · 2 shared papers, 2020–2021 · strength 0.16
  12. Adnan M. Nagrial · 2 shared papers, 2018 · strength 0.14
  13. Claire Vennin · 2 shared papers, 2018–2021 · strength 0.13
  14. Thomas R. Cox · 2 shared papers, 2018–2021 · strength 0.13
  15. Sean Michael Grimmond · 2 shared papers, 2018–2021 · strength 0.13
  16. Jennifer P. Morton · 2 shared papers, 2018–2021 · strength 0.13
  17. Owen James Sansom · 2 shared papers, 2018–2021 · strength 0.13
  18. Andrew Victor Biankin · 2 shared papers, 2018–2021 · strength 0.13
  19. Kai Wang · 1 shared paper, 2019 · strength 0.10
  20. Samantha Richelle Oakes · 1 shared paper, 2020 · strength 0.09
  21. Kai Wang · 1 shared paper, 2018 · strength 0.08
  22. Andrew P. Barbour · 1 shared paper, 2020 · strength 0.08
  23. John David Hooper · 1 shared paper, 2020 · strength 0.08
  24. Thomas Kryza · 1 shared paper, 2020 · strength 0.08
  25. Yingxiao Wang · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.